It refers to a pharmacological composition, including at least 150 mg and up to 700 mg of cerium, and more than 40% and more than 70% of cerium according to the total weight of the pharmacological composition, The ingredients include grain, which is essentially made of cherries, and a polymer, where the grain can be obtained from the humeda grain, which is almidon, hippromelosa, povidona, and so on,This composition also includes other pre suckers. It also refers to a form of pharmacology and a process of acquisition. This synthesis suppresses the use of enzyme kinase (ALK) in the treatment of diffuse diseases such as non-small cell lung cancerSe refiere a una composicion farmaceutica que comprende al menos 150 mg y hasta 700 mg de Ceritinib y mas de 40% y hasta 70% por peso de Ceritinib con base en el peso total de la composicion farmaceutica, en donde la composicion comprende granulos que consisten sustancialmente de Ceritinib y un aglutinante donde los granulos son obtenibles mediante granulacion humeda； el aglutinante es almidon, hipromelosa, povidona, entre otros, dicha composicion comprende ademas otros excipientes. Tambien se refiere a una forma farmaceutica y un proceso de obtencion. Dicha composicion inhibe la enzima quinasa del linfoma anaplasico (ALK) siendo util en el tratamiento de enfermedad proliferativa tal como cancer de pulmon de celulas no pequenas
